Back to results
Not yet recruitingPhase 2

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

NCT07539753

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

Contact

Guangyu Yao, MD PhD

+86-13570966868yaogy@sum.edu.cn
View on ClinicalTrials.gov
Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases — TrialFind